|
CENTER PUBLICATIONS Publications prepared during the past four years since the onset of the current grant cycle in 1996 are listed next in alphabetical order. Publications are listed in the Progress Report for individual MRRC investigators (see Section B), according to the author's primary affiliation in one of the four MRRC programs, i.e., Genetics, Developmental Biology, Basic Neuroscience, and Clinical Neuroscience/Behavior. |
| Albers, S.; Levy, H.L., One more thought on sudden infant death syndrome, Pediatrics , 2001, 107, 809 |
Albers, S.; Levy, H.L.; Irons, M.; Strauss, A.W.; Marsden, D., Compound heterozygosity in four asymptomatic siblings with medium-chain acyl-CoA dehydrogenase deficiency, J. Inherit. Metab. Dis. , 2001, 24, 417-418 pubmed |
Albers, S.; Marsden, D.; Quackenbush, E.; Stark, A.R.; Levy, H.L.; Irons, M., Detection of neonatal CPT II deficiency by expanded newborn screening, Pediatrics , 2001, 107, 1-4 |
Albers, S.; Marsden, D.; Quackenbush, E.; Stark, A.R.; Levy, H.L.; Irons, M., Detection of neonatal carnitine palmitoyltransferase II deficiency by expanded newborn screening with tandem mass spectrometry, Pediatrics , 2001, 107, E103 pubmed |
Albers, S.; Waisbren, S.E.; Ampola, M.G.; Brewster, T.G.; Burke, L.W.; Demmer, L.A.; Filiano, J.; Greenstein, R.M.; Ingham, C.L.; Korson, M.S.; Marsden, D.; Schwartz, R.C.; Seashore, M.R.; Shih, V.E.; Levy, H.L., New England Consortium: a model for medical evaluation of expanded newborn screening with tandem mass spectrometry, J. Inherit. Metab. Dis. , 2001, 24, 303-4 pubmed |
Albers, S.; Waisbren, S.E.; Ampola, M.G.; Brewster, T.G.; Burke, L.W.; Demmer, L.A.; Filiano, J.; Greenstein, R.M.G.; Ingham, C.L.; Korson, M.S.; Marsden, D.; Schwartz, R.C.; Seashore, M.R.;Shih, V.E.; Levy, H.L., A model for medical evaluation of expanded newborn screening with tandem mass spectrometry, J. Inherit. Metab. Dis. , 2001, 24, 303-304 pubmed |
Albert, M.S.; Kacher, D.F.; Balamore, D.; Venkatesh, A.K.; Jolesz, F.A., T(1) of (129)Xe in blood and the role of oxygenation [In Process Citation], J. Magn. Reson. , 1999, 140, 264-73 |
Albert, M.S.; Tseng, C.H.; Williamson, D.; Oteiza, E.R.; Walsworth, R.L.; Kraft, B.; Kacher, D.; Holman, B.L.; Jolesz, F.A., Hyperpolarized 129Xe MR imaging of the oral cavity, J. Magn. Reson. , 1996, 111, 204-7 |
Alberta, J.; Park, S.K.; Mora, J.; Yuk, D.; Pawlitzky, I.; Iannarelli, P. ;Vartanian, T.; Stiles, C.D.; Rowitch, D.H., Sonic hedgehog signaling is required during an early phase of oligodendrocyte development in the mammalian brain, M.C.N. , 2001, 18, 434-444 pubmed |
Alberta, J.A.; Auger, K.R.; Batt, D.; Iannerelli, P.; Kwang, G.; Elliott, H.L.; Duke, R.; Roberts, T.M.; Stiles, C.D., Platelet-derived growth factor stimulation of monocyte chemoattractant protein-1 gene expression is mediated by transient activation of the phosphoinositide 3-kinase signal transduction pathway, J. Biol. Chem. , 1999, 274, 31062-31067 |
Alberta, J.A.; Springett, G.M.; Rayburn, H.; Natoli, T.A.; Loring, J.; Kreidberg, J.A.; Housman, D., Role of the WT1 tumor suppressor in murine hematopoiesis, Blood , 2003, 101, 2570-4 pubmed |
Alberta, J.A.; Stiles, C.D., Phosphorylation-directed antibodies in high-flux screens for compounds that modulate signal transduction, Biotechniques , 1997, 23, 490-493 |
Alexander R, Judkins AR, Burger PC, Hamilton RL, Kleinschmidt-DeMasters B, Perry A, Pomeroy SL, Rosenblu M, Yachnis AT, Zhous H, Rorke LB, Biegel J, INI 1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma, J Neuropath EXP Neurol , 2005, 64, 391-7 |
Alexander, C.M.; Reichsman, F.; Hinkes, M.T.; Lincecum, J.; Becker, K.A.; Cumberledge, S.; Bernfield, M., Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice, Nat. Genet. , 2000, 25, 329-32 pubmed |
Alexander, E.; Moriarty, T.M.; Kikinis, R.; Jolesz, F.A., Innovations in minimalism: intraoperative MRI, Clin. Neurosurg. , 1996, 43, 338-52 |
Ali, I.U.; Senger, D.R.; Smith, L.E., Angiogenesis as a potential biomarker in prostate cancer chemoprevention trials, Urology , 2001, 57, 143-147 |
Allen, K.M.; Gleeson, J.G.; Bagrodia, S.; Partington, M.W.; MacMillan, J.C.; Cerione, R.A.; Mulley, J.C.; Walsh, C.A., PAK3 mutation in nonsyndromic X-linked mental retardation, Nat. Genet. , 1998, 20, 25-30 |
Allen, K.M.; Gleeson, J.G.; Shoup, S.M.; Walsh, C.A., A YAC contig in Xq22.3-q23, from DXS287 to DXS8088, spanning the brain-specific genes doublecortin (DCX) and PAK3, Genomics , 1998, 52, 214-8 |
Allen, K.M.; Walsh, C.A., Genes that regulate neuronal migration in the cerebral cortex, Epilepsy Res. , 1999, 36, 143-154 |
Allocco, D.J.; Kohane, I.S.; Butte, A.J., Quantifying the relationship between co-expression, co-regulation and gene function., B.M.C. Bioinformatics. , 2004 , 5(1), 18 pubmed |